Arca Biopharma | ABIO - Ordinary Share Capital


Arca Biopharma reported $48.72M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Amgen USD 540M 1000K Mar/2026
Arca Biopharma USD 48.72M 338K Dec/2025
Biogen USD 146.7M 200K Sep/2025
Brainstorm Cell Therapeutics USD 11.04M 2K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Capricor Therapeutics USD 57.37M 11.65M Dec/2025
Cipla INR 807.78M 17K Mar/2026
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1000 Mar/2026
CSL USD 482.13M 93.87M Dec/2025
Cytokinetics USD 124.43M 2.17M Mar/2026
Daiichi Sankyo JPY 1.85B 9K Dec/2025
Gilead Sciences USD 1.24B 1000K Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
Grifols EUR 680.58M 846.11K Dec/2025
Laboratory Of America USD 82.3M 100K Mar/2026
Myriad Genetics USD 93.5M 400K Dec/2025
Otsuka Holdings JPY 527.31M 824K Mar/2026
Pfizer USD 5.7B 13M Mar/2026
United Therapeutics USD 42.16M 1.49M Mar/2026